There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The progressive loss of muscle regenerative capacity with age or disease results in
part from a decline in the number and function of satellite cells, the direct cellular
contributors to muscle repair. However, little is known about the molecular effectors
underlying satellite cell impairment and depletion. Elevated levels of inflammatory
cytokines, including interleukin-6 (IL-6), are associated with both age-related and
muscle-wasting conditions. The levels of STAT3, a downstream effector of IL-6, are
also elevated with muscle wasting, and STAT3 has been implicated in the regulation
of self-renewal and stem cell fate in several tissues. Here we show that IL-6-activated
Stat3 signaling regulates satellite cell behavior, promoting myogenic lineage progression
through myogenic differentiation 1 (Myod1) regulation. Conditional ablation of Stat3
in Pax7-expressing satellite cells resulted in their increased expansion during regeneration,
but compromised myogenic differentiation prevented the contribution of these cells
to regenerating myofibers. In contrast, transient Stat3 inhibition promoted satellite
cell expansion and enhanced tissue repair in both aged and dystrophic muscle. The
effects of STAT3 inhibition on cell fate and proliferation were conserved in human
myoblasts. The results of this study indicate that pharmacological manipulation of
STAT3 activity can be used to counteract the functional exhaustion of satellite cells
in pathological conditions, thereby maintaining the endogenous regenerative response
and ameliorating muscle-wasting diseases.
Modified muscle use or injury can produce a stereotypic inflammatory response in which neutrophils rapidly invade, followed by macrophages. This inflammatory response coincides with muscle repair, regeneration, and growth, which involve activation and proliferation of satellite cells, followed by their terminal differentiation. Recent investigations have begun to explore the relationship between inflammatory cell functions and skeletal muscle injury and repair by using genetically modified animal models, antibody depletions of specific inflammatory cell populations, or expression profiling of inflamed muscle after injury. These studies have contributed to a complex picture in which inflammatory cells promote both injury and repair, through the combined actions of free radicals, growth factors, and chemokines. In this review, recent discoveries concerning the interactions between skeletal muscle and inflammatory cells are presented. New findings clearly show a role for neutrophils in promoting muscle damage soon after muscle injury or modified use. No direct evidence is yet available to show that neutrophils play a beneficial role in muscle repair or regeneration. Macrophages have also been shown capable of promoting muscle damage in vivo and in vitro through the release of free radicals, although other findings indicate that they may also play a role in muscle repair and regeneration through growth factors and cytokine-mediated signaling. However, this role for macrophages in muscle regeneration is still not definitive; other cells present in muscle can also produce the potentially regenerative factors, and it remains to be proven whether macrophage-derived factors are essential for muscle repair or regeneration in vivo. New evidence also shows that muscle cells can release positive and negative regulators of inflammatory cell invasion, and thereby play an active role in modulating the inflammatory process. In particular, muscle-derived nitric oxide can inhibit inflammatory cell invasion of healthy muscle and protect muscle from lysis by inflammatory cells in vivo and in vitro. On the other hand, muscle-derived cytokines can signal for inflammatory cell invasion, at least in vitro. The immediate challenge for advancing our current understanding of the relationships between muscle and inflammatory cells during muscle injury and repair is to place what has been learned in vitro into the complex and dynamic in vivo environment.
Interleukin (IL)‐6 is a cytokine with pleiotropic functions in different tissues and organs. Skeletal muscle produces and releases significant levels of IL‐6 after prolonged exercise and is therefore considered as a myokine. Muscle is also an important target of the cytokine. IL‐6 signaling has been associated with stimulation of hypertrophic muscle growth and myogenesis through regulation of the proliferative capacity of muscle stem cells. Additional beneficial effects of IL‐6 include regulation of energy metabolism, which is related to the capacity of actively contracting muscle to synthesize and release IL‐6. Paradoxically, deleterious actions for IL‐6 have also been proposed, such as promotion of atrophy and muscle wasting. We review the current evidence for these apparently contradictory effects, the mechanisms involved and discuss their possible biological implications.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.